Unleashing the power of autoantibodies to advance precision medicine

Driving discovery of next-gen biomarkers with novel seromics technologies and services.

One partner with a range of services

Vaccine Development

Systems Serology

Autoantibody Biomarker Profiling

Bioinformatics

Oncology Drug Screening

Custom Arrays

Industry-first seromics technologies

Our patented KREX^® protein folding technology and our ORVAR^® autoantigen discovery technology provide unique capabilities that accelerate the discovery of clinically relevant biomarkers.

Explore Our Technologies

1 2 3 4

Biotech company

So useful! We are very excited about the data.

– Biotech company

Academic institution

Really cool that you can screen that much in a short amount of time.

– Academic institution

Large pharma company

We need this in all of our projects.

– Large pharma company

Large pharma company

This is certainly clinically relevant data.

– Large pharma company

Featured Service

Autoantibody Profiling

Discover and validate new autoantibody biomarkers and biomarker signatures with unmatched specificity and reproducibility.

Learn More

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

Design and development by RainCastle Communications.